AOC Pharma S.à r.l. Updates Stakeholding in Fagron NV
Recent Notification from AOC Pharma S.à r.l.
Fagron has recently received important notification regarding changes in shareholding from AOC Pharma S.à r.l. This communication comes under Belgian laws that govern the disclosure of significant shareholdings in publicly traded companies. These rules are designed to ensure transparency in ownership structures and help maintain market integrity.
Details of the Notification
On a specific date, Fagron acknowledged that while there were changes in the chain of controlled undertakings associated with its shares, no critical notification thresholds were crossed. Specifically, AOC Pharma S.à r.l. maintained its share count in Fagron NV, which remains stable amidst the changes within its ownership structure.
Ownership Structure Insight
As per the notification received, AOC Pharma S.à r.l. directly holds 11.06% of the voting rights of Fagron NV. This data indicates a firm grasp of their position within the company and points towards their ongoing commitment as stakeholders. Notably, this stake has not fluctuated despite alterations in the chain of control.
Chain of Controlled Undertakings
The notification outlines AOC Pharma's connection through several corporate layers. AOC Pharma S.à r.l. is controlled by Active Ownership Fund SICAV-FIS SCS. This fund has appointed Active Ownership Corporation S.à r.l. as its alternative investment fund manager. A roadmap of control illustrates how this complex structure involves various entities and shareholders, indicating a detailed hierarchy where accountability and authority lie.
Understanding Voting Rights
AOC Pharma S.à r.l.'s cumulative total voting rights comprises 8,102,492 rights based on a denominator of 73,228,904. This signifies consistent backing and support for Fagron NV’s strategies and operational maneuvers within the competitive pharmaceutical landscape. Keeping up with percentages provides an overview of stakeholder influence and the potential power dynamics at play in corporate governance.
About Fagron
Fagron proudly stands as a leading global player in the field of pharmaceutical compounding, delivering individualized medications across hospitals, clinics, pharmacies, and directly to patients. Operating in over 30 countries, the company prioritizes tailored medicine solutions to enhance patient care and treatment outcomes.
The Belgian firm, with its headquarters situated in Nazareth and also listed on major European financial platforms Euronext Brussels and Euronext Amsterdam under the ticker symbol 'FAGR', continues to expand its operational footprint while surfing the waves of innovation and customer-centric approaches.
Further Information
If further questions arise regarding this notification or other matters concerning Fagron, stakeholders and interested parties can connect with Karin de Jong, the Chief Financial Officer, for a comprehensive understanding.
Frequently Asked Questions
What does the notification from AOC Pharma S.à r.l. signify?
The notification indicates that AOC Pharma S.à r.l. is maintaining its shareholding in Fagron NV without crossing any significant thresholds.
What percentage of voting rights does AOC Pharma S.à r.l. hold?
AOC Pharma S.à r.l. holds 11.06% of the total voting rights in Fagron NV.
How is the stake of AOC Pharma structured?
AOC Pharma's ownership structure is complex, involving several controlled undertakings and layers, primarily linked to Active Ownership Fund SICAV-FIS SCS.
What role does Fagron play in the pharmaceutical industry?
Fagron is a key player in pharmaceutical compounding, focusing on personalized medicine solutions across multiple global markets.
Who can I contact for more information about Fagron?
Karin de Jong, the Chief Financial Officer at Fagron, is the primary contact for inquiries related to the company and its operations.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- NOVONIX and ICoNiChem Team Up for Sustainable Battery Solutions
- FTSE Russell Welcomes India and South Korea Bonds to Indexes
- SALCO's $9 Million Investment in Limitless' $GEMS Tokens
- NOVONIX Partners with ICoNiChem for Sustainable Battery Materials
- Analyzing the Impact of Hurricane Milton on Florida Homes
- Unlocking the Economic Potential of Second-Hand Clothing
- How Second-Hand Clothing Fuels Economic Growth in Africa
- Impact of Second-Hand Clothing on Global Economies and Employment
- Rollins, Inc. Announces Upcoming Financial Results Release
- Market Reactions: Fed's Policies and China's Economic Landscape
Recent Articles
- Enhabit Home Health Announces Upcoming Earnings Call Details
- MetLife Reports Fourth Quarter Dividend for Shareholders
- PrairieSky Royalty Sets Date for Q3 Financial Results Call
- Understanding the Transformative Role of Placental Tissue for Healing
- The Arena Group Faces NYSE Compliance Challenge: Next Steps
- Rhythm Pharmaceuticals Expands Team with New Stock Grants
- Terreno Realty Corporation Reports Q3 Performance and Developments
- How a Young Investor Boosted Their Dividend Income Effectively
- Crinetics Pharmaceuticals Pursues $400 Million Stock Offering
- Investigation Launched into Stitch Fix, Inc. Financial Results
- TC Energy Corporation Cash Tender Offers: Key Insights
- Nvidia's Promising Surge: What Investors Should Know
- WM Technology Faces SEC Investigation: What Investors Should Know
- ImmuCell Reports Strong Q3 2024 Sales Growth and Strategic Moves
- Investigation Launched into Acadia Healthcare Company Amid Concerns
- Innovative Collaboration: Triton Digital and NZME's Audio Future
- T2 Biosystems Announces Upcoming Business Update Call Details
- Rani Therapeutics Highlights Innovations at Upcoming Virtual Summit
- Opportunity for Bumble Inc. Investors to Join Class Action Suit
- Bumble Inc. Investors: Join Class Action Lawsuit Now!
- Elcora Markets Update: Management Cease Trade Order Status
- Investigation Launched into Medpace Holdings, Inc. by Legal Firm
- Opportunity for Super Micro Computer Investors Amid Legal Action
- Hanmi Financial Unveils Q3 2024 Earnings and Upcoming Call
- Profiting from Ascendis Pharma: A 10-Year Investment Journey
- HBT Financial Sets Date for Q3 2024 Financial Results Release
- Investor Inquiry into 2seventy bio, Inc. Raises Concerns
- Transform Your $1,000 Investment into Over $2,100 Today!
- Myriad Genetics Enhances Breast Cancer Research with Collaborations
- Investigation Launched for Fortrea Holdings Inc. - What You Need to Know
- HAPO Community Credit Union's Strategic Acquisition Move
- AvidXchange Schedules Third Quarter 2024 Financial Update
- Investigation into SAP SE Sparks Interest Among Investors
- PrairieSky Royalty Unveils Q3 2024 Conference Call Details
- Vicor Corporation Announces Earnings Call for Investors
- LTC Global Expands Its Portfolio with LTCR Acquisition
- Saratoga Investment's Impressive Q2 2025 Financial Performance
- TC Energy's Cash Tender Offers: A Comprehensive Overview
- Square Unveils Innovative Orders Platform for Sellers
- AvidXchange to Release Third Quarter Financial Results Soon
- Andy Florance Honored as a 2024 Tech Titan for Innovation
- FutureFuel Set to Reveal Exciting Q3 2024 Financial Insights
- Empowering Older Women Voters to Shape Pennsylvania's Future
- ImmuCell Reports Strong Sales Growth in 2024 Q3 Performance
- Atlassian Set to Unveil First Quarter FY 2025 Results Soon
- T2 Biosystems Plans Key Business Update Call Soon
- Chalice Medical's CMO8 Oxygenator: A Game Changer for Healthcare
- Palmer Square Capital BDC Plans Earnings Call for Q3 2024 Results
- Investigation into Securities Claims for Lions Gate Shareholders
- Vicor Corporation's Upcoming Earnings Call Details Revealed